CAPR INVESTIGATION: Block & Leviton Seeks to Speak With Capricor Therapeutics Investors
Boston, Massachusetts--(Newsfile Corp. - July 31, 2026) - Block & Leviton is investigating Capricor Therapeutics (NASDAQ: CAPR) for potential securities law violations. Investors who have lost money in their Capricor Therapeutics investment should contact the firm to learn more about how they might recover those losses.